JP Morgan Chase’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

JP Morgan Chase’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,484	Closed	-$85K	–	7228
2022 Q1	$85K	Sell	28,484 -10,542	-27%	-$23.2K	﹤0.01%	5589
2021 Q4	$50K	Buy	39,026 +7,289	+23%	+$14.6K	﹤0.01%	5952
2021 Q3	$72K	Buy	31,737 +16,020	+102%	+$57.6K	﹤0.01%	5721
2021 Q2	$89K	Buy	+15,717	New	+$105K	﹤0.01%	5582
2020 Q4	–	Sell	-708,021	Closed	-$7.28M	–	6086
2020 Q3	$7.28M	Buy	708,021 +608,021	+608%	+$6.27M	﹤0.01%	2282
2020 Q2	$1M	Hold	100,000	–	–	﹤0.01%	3512
2020 Q1	$985K	Buy	+100,000	New	+$987K	﹤0.01%	3411

JP Morgan Chase's TLMD Position: Q2 2022 in Review

JP Morgan Chase sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 28,484 shares — an estimated $85K sold.

JP Morgan Chase first reported a position in TLMD in Q1 2020 and held it in 7 quarters. The position peaked at $7.28M in Q3 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

JP Morgan Chase reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
JP Morgan Chase sold 28,484 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $85K.
JP Morgan Chase first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 7 quarters.
JP Morgan Chase's SOC Telemed, Inc. Class A Common Stock position peaked at $7.28M in Q3 2020.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.